These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9086785)

  • 1. [The old and new problems of the antibiotics treatment in hemorrhagic enterocolitis and hemolytic uremic syndrome, according to Japanese epidemiological studies].
    Kohsaka T; Tagawa M; Suzuki T; Ito H
    Nihon Rinsho; 1997 Mar; 55(3):706-14. PubMed ID: 9086785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retrospective analysis of the relationship between HUS incidence and antibiotics among patients with Escherichia coli O157 enterocolitis in the Sakai outbreak].
    Higami S; Nishimoto K; Kawamura T; Tsuruhara T; Isshiki G; Ookita A
    Kansenshogaku Zasshi; 1998 Mar; 72(3):266-72. PubMed ID: 9643979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of diarrhea-associated hemolytic uremic syndrome in children.
    Iijima K; Kamioka I; Nozu K
    Clin Exp Nephrol; 2008 Feb; 12(1):16-9. PubMed ID: 18175052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996.
    Fukushima H; Hashizume T; Morita Y; Tanaka J; Azuma K; Mizumoto Y; Kaneno M; Matsuura M; Konma K; Kitani T
    Pediatr Int; 1999 Apr; 41(2):213-7. PubMed ID: 10221032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for the development of Escherichia coli O157:H7 associated with hemolytic uremic syndrome.
    Kawamura N; Yamazaki T; Tamai H
    Pediatr Int; 1999 Apr; 41(2):218-22. PubMed ID: 10221033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of early oral fluoroquinolones in hemorrhagic colitis due to Escherichia coli O157:H7.
    Shiomi M; Togawa M; Fujita K; Murata R
    Pediatr Int; 1999 Apr; 41(2):228-32. PubMed ID: 10221035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical course and laboratory data of hemorrhagic colitis caused by Escherichia coli O157:H7].
    Kawamura T
    Rinsho Byori; 1997 Sep; 45(9):865-8. PubMed ID: 9311260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Shiga-toxin-producing Escherichia coli in hemorrhagic colitis and hemolytic uremic syndrome.
    Cleary TG
    Semin Pediatr Infect Dis; 2004 Oct; 15(4):260-5. PubMed ID: 15494950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and treatment of children with hemolytic uremic syndrome caused by enterohemorrhagic Escherichia coli O157:H7 infection: experience of an outbreak in Sakai City, 1996.
    Yoshioka K; Yagi K; Moriguchi N
    Pediatr Int; 1999 Apr; 41(2):223-7. PubMed ID: 10221034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing the development of hemolytic uremic syndrome caused by enterohemorrhagic Escherichia coli infection: from a questionnaire survey to in vitro experiment.
    Honda T
    Pediatr Int; 1999 Apr; 41(2):209-12. PubMed ID: 10221031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sporadic cases of hemolytic uremic syndrome and hemorrhagic colitis with serum IgM antibodies to lipopolysaccharides of enterohemorrhagic Escherichia coli O157].
    Shiomi M; Togawa M
    Nihon Rinsho; 1997 Mar; 55(3):686-92. PubMed ID: 9086782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum IL-10 and endothelin levels in hemolytic uremic syndrome caused by Escherichia coli O157.
    Yamamoto T; Nagayama K; Satomura K; Honda T; Okada S
    Nephron; 2000 Apr; 84(4):326-32. PubMed ID: 10754409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of hemolytic uremic syndrome with hemorrhagic colitis due to Escherichia coli O111 infection].
    Kim JP; Han DS; Paik CH; Chung YW; Kim JB; Sohn JH; Hahm JS
    Korean J Gastroenterol; 2005 May; 45(5):365-8. PubMed ID: 15908771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte P1 group antigen expression in VTEC-associated hemolytic uremic syndrome.
    Ashida A; Matsui K; Chizaki T; Yoshikawa K; Kawamura N; Suzuki K; Tamai H
    Clin Nephrol; 1999 Feb; 51(2):73-6. PubMed ID: 10069641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota.
    Smith KE; Wilker PR; Reiter PL; Hedican EB; Bender JB; Hedberg CW
    Pediatr Infect Dis J; 2012 Jan; 31(1):37-41. PubMed ID: 21892124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemorrhagic colitis and hemolytic-uremic syndrome--E. coli as the etiologic agent. I. Bacteriology and pathogenesis].
    Tschäpe H; Böhme G
    Kinderarztl Prax; 1991 Jun; 59(6):161-5. PubMed ID: 1921166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory mediators in Escherichia coli O157:H7 hemorrhagic colitis and hemolytic-uremic syndrome.
    Proulx F; Turgeon JP; Litalien C; Mariscalco MM; Robitaille P; Seidman E
    Pediatr Infect Dis J; 1998 Oct; 17(10):899-904. PubMed ID: 9802632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The drug sensitivity of enterohemorragic Escherichia coli and antibiotics treatment for hemorrhagic enterocolitis--from an outbreak of enterocolitis in Sakai city].
    Moriguchi N; Yagi K; Yamamoto T; Yoshioka K; Kubo S
    Jpn J Antibiot; 1997 Jul; 50(7):591-6. PubMed ID: 9743905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemolytic uremic syndrome associated with entero-hemorrhagic Escherichia coli].
    Takeda T
    Nihon Rinsho; 1993 Jan; 51(1):198-203. PubMed ID: 8433519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.